Swipe om te navigeren naar een ander artikel
The purpose of this study was to evaluate the responsiveness of the EQ-5D and the Parkinson’s Disease Questionnaire (PDQ-8) to deterioration in health-related quality of life (HRQoL) in patients with Parkinson’s disease (PD).
HRQoL and clinical data collected from 31 patients with PD (male: 74.2%, mean age: 61 years) who were surveyed with the EQ-5D and the PDQ-8 questionnaires in 2002 and 2006/2007 were analyzed. Responsiveness of the EQ-5D, PDQ-8, and Hoehn and Yahr (H&Y) staging were assessed according to Cohen’s effect size (ES) and standardized response mean (SRM).
The mean (standard deviation) EQ-5D index and PDQ-8 summary index (PDQ-8SI) scores were 0.76 (0.23) and 17.7 (14.2) at baseline and 0.52 (0.33) and 35.1 (17.4) at year four. Based on both ES and SRM indices, the rank order of responsiveness of the studied measures, from high to low, was PDQ-8SI (ES = 1.22), EQ-5D index score (ES = 1.06), H&Y score (ES = 0.82), and the EQ-VAS score (ES = 0.24).
Both the EQ-5D and PDQ-8 are responsive to changes in health burden of the Parkinson’s disease over a 4-year period.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Gold, M. R., Patrick, D. L., Torrance, D. G., et al. (1996). Identifying and valuing outcomes. In M. R. Gold (Ed.), Cost-effectiveness in health and medicine (pp. 82–134). New York, NY: Oxford University Pres.
Drummond, M. F., O’ Brien, B. J., & Stoddart, G. L. (1997). Cost-utility analysis. In: Methods for the economic evaluation of health care programmes (2nd ed.). Oxford: Oxford University Press, pp 139–199.
Schrag, A., Selai, C., Jahanshahi, M., & Quinn, N. P. (2000). The EQ-5D–a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 69, 67–73. CrossRef
Luo, N., Low, S., Lau, P. N., Au, W. L., & Tan, L. C. S. (2009). Is EQ-5D a valid quality of life instrument in patients with Parkinson’s disease? A study in Singapore. Annals of the Academy of Medicine, Singapore, 38, 521–528. PubMed
Reuther, M., Spottke, E. A., & Klotsche, J. (2007). Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism & Related Disorders, 13, 108–114. CrossRef
Reichmann, H., Boas, J., Macmahon, D., Myllyla, V., Hakala, A., Reinikainen, K., et al. (2005). Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations. Acta Neurologica Scandinavica, 111, 21–28. CrossRefPubMed
Karlsen, K. H., Tandberg, E., Arsland, D., & Larsen, J. P. (2000). Health related quality of life in Parkinson’s disease: A prospective longitudinal study. Journal of Neurology, Neurosurgery and Psychiatry, 69, 584–589. CrossRef
Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The PDQ-8: Development and validation of a short-form Parkinson’s disease questionnaire. Psychology Health, 12, 805–814. CrossRef
Tan, L. C. S., Luo, N., Nazri, M., Li, S. C., & Thumboo, J. (2004). Validity and reliability of the PDQ-39 and PDQ-8 in English-speaking patients in Singapore. Parkinsonism & Related Disorders, 10, 493–499. CrossRef
Fahn, S., Marsden, C. D., Calne, D. B., & Goldstein, M. (Eds.). (1987). Recent developments in Parkinson’s Disease (Vol. 2, pp. 153–163). Florham Park, NJ: Macmillan Health Care Information.
Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment analysis and interpretation. Chichester: Wiley.
Cohen, J. (1998). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Earlbaum Associates.
- Responsiveness of the EQ-5D and 8-item Parkinson’s Disease Questionnaire (PDQ-8) in a 4-year follow-up study
Louis CS Tan
- Springer Netherlands